A double-blind trial in 600 patients with grade I, II, and III chronic cerebral ischemia demonstrated the high clinical efficacy of Cytoflavin, an antioxidant and energy corrector, at a dose of two tablets twice daily for 25 days, as compared with a placebo. Patients receiving Cytoflavin showed reductions in the severity of the main symptoms, improvements in balance and gait functions, decreases in the severity of both asthenic and neurotic syndromes, and improvements in cognitive functions. Cytoflavin had positive effects on sleep quality and all aspects of patient’s activities of daily living.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. I. Gusev and V. I. Skvortsova, Cerebral Ischemia [in Russian], Meditsina, Moscow (2001).
A. L. Kovalenko, Pharmacological Activity of Original Medicines Based on 1-Deoxy-2(N-Methylamino)-D-Glucitol [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, St. Petersburg (2005).
A. L. Kovalenko, M. G. Romantsov, and A. Yu. Petrov, “Pharmacological activity of succinic acid and the potential for its clinical use,” in: Collected Articles [in Russian], M. G. Romantsov (ed.), pp. 6–20.
S. A. Rumyantseva and E. V. Silina, “Energy correction and the quality of life in chronic cerebral ischemia,” Meditsinskaya Kniga, Moscow (2007).
S. A. Rumyantseva, E. V. Silina, and I. V. Koryukova, “Complex neurotransmitter therapy of acute and chronic ischemic brain lesions,” Zh. Atmos. Nervn. Bolez., 2, 1–6 (2008).
S. A. Rumyantseva, A. I. Fedin, E. V. Silina, and S. B. Bolevich, Antioxidant Neuroprotection in Stroke [in Russian], Taktik-Studio, St. Petersburg (2008).
E. Yu. Solovieva, O. P. Mironova, O. A. Baranova, et al., “Free-radical processes and antioxidant therapy in chronic cerebral ischemia,” Zh. Nevrol. Psikhiat., 6, 98–104 (2008).
E. Yu. Solovieva, Chronic Ischemia and Oxidative Stress. Clinical-Pathogenetic and Prognostic Aspects [in Russian], Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (2009).
Z. A. Suslina, A. I. Fedin, S. A. Rumyantseva, et al., “Clinical efficacy of Cytoflavin in dyscirculatory encephalopathy (results of a multicenter, randomized trial),” Vestn. SPb GMA im. I. I. Mechnikova, No. 3, No. 6, 7–14 (2005).
A. I. Fedin and S. A. Rumyantseva, Intensive Therapy of Ischemic Stroke [in Russian], Meditsinskaya Kniga, Moscow (2004).
A. I. Fedin, S. A. Rumyantseva, M. A. Piradov, et al., “Efficacy of the neurometabolic protector Cytoflavin in cerebral infarct (multicentre, randomized trial),” Vestn. SPb GMA im. I. I. Mechnikova, No. 1, 13–19 (2005).
A. N. Belova and O. N. Shepetova (eds.), Scales, Tests, and Questionnaires in Medical rehabilitation [in Russian], Avtodor, Moscow (2005), pp. 205–224.
H. Kontos, “Oxygen radicals in cerebral ischemia,” Willis Lecture Stroke, 32, 2712–2716 (2001).
K. Niizuma, H. Endo, and P. Chan, “Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival,” J. Neurochem., 109, 133–138 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 111, No. 3, pp. 25–30, March, 2011.
Rights and permissions
About this article
Cite this article
Suslina, Z.A., Rumyantseva, S.A., Tanashyan, M.M. et al. Complex Energy Correction in Chronic Cerebral Ischemia. Neurosci Behav Physi 42, 537–542 (2012). https://doi.org/10.1007/s11055-012-9597-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-012-9597-8